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YeastAlthoughmitochondria are essential organelles for long-term survival of eukaryotic cells, recent discoveries in
biochemistry and genetics have advanced our understanding of the requirements for mitochondria in cell
death. Much of what we understand about cell death is based on the identiﬁcation of conserved cell death
genes in Drosophila melanogaster and Caenorhabditis elegans. However, the role of mitochondria in cell death
in these models has been much less clear. Considering the active role that mitochondria play in apoptosis in
mammalian cells, themitochondrial contribution to cell death in non-mammalian systems has been an area of
active investigation. In this article, we review the current research on this topic in three non-mammalian
models, C. elegans, Drosophila, and Saccharomyces cerevisiae. In addition, we discuss how non-mammalian
models have provided important insight into the mechanisms of human disease as they relate to the
mitochondrial pathway of cell death. The unique perspective derived from each of these model systems
provides a more complete understanding of mitochondria in programmed cell death. This article is part of a
Special Issue entitled Mitochondria: the deadly organelle.ondria: the deadly organelle.
al School, Bldg 149, 13th St,
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Apoptosis and other forms of programmed cell death have been
investigated for the past century using genetically tractable non-
mammalian eukaryotes such as Drosophila melanogaster and Caenor-
habditis elegans. These studies have facilitated the characterization of
a large number of conserved genes and signaling networks. Most of
these networks are at least partially conserved in mammals, including
those that regulate programmed cell death. Apoptosis is by far the
best studied of the cell death mechanisms. Caspases, the critical
effector proteases of apoptosis, were ﬁrst identiﬁed in a screen for C.
elegans mutants lacking developmental programmed cell death [1].
Sequence similarity between the worm CED-3 gene and a mammalian
protein (ICE, Caspase-1) assigned protease function to this gene [2].
Similar to the orthologous CED-9, Bcl-2 was shown to promote cell
survival [3]. The inhibitor of apoptosis (IAP) proteins were originally
identiﬁed as cell death inhibitors in baculoviruses that infect insect
cells and were later found to be essential regulators of apoptosis in
Drosophila [4,5] and mammals [6,7]. The central pro-apoptotic
regulators in Drosophila, Reaper, Hid, and Grim, were found to
antagonize IAP-mediated caspase inhibition [8–12]. In addition to thefundamental contribution of non-mammalian models to the under-
standing of apoptotic cell death, genetic screens for mutants affecting
autophagy, primarily in S. cerevisiae, have identiﬁed and partially
characterized most of genes involved in this process [13]. Only
recently have the autophagy pathways become avidly studied in
mammals [14] or shown to contribute to cell death [15]. Studies in
multiple organisms have provided valuable insight into cell death
mechanisms that can only come from viewing a problem from
multiple perspectives. However, there appears to be a dichotomy
regarding the role of mitochondria as a central component of the
apoptotic machinery, between mammals and other eukaryotes [16],
and even between different non-mammalian eukaryotes [17].
In mammalian systems, mitochondria are intimately involved in
the intrinsic cell death pathway. The pro-apoptotic Bcl-2 members
BAX and BAK, BID, and others, initiate the mitochondrial cell death
pathway by permeabilizing the mitochondrial outer membrane. Pro-
apoptotic factors released from the mitochondria include cytochrome
c (Cyt-c), which binds to the adaptor protein Apaf-1 causing
activation of Caspase-9 and downstream caspases. In addition to the
release of Cyt-c, there are additional mitochondrial alterations that
may contribute to cell death in mammals. These include disruption of
electron transport, oxidative phosphorylation, and adenosine triphos-
phate (ATP) production, release of other proteins that trigger caspase
activation, and changes of cellular reduction–oxidation (redox)
potential [18]. Additionally, these organelles undergo signiﬁcant
ultrastructural changes during apoptosis. Considering the active role
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become the prime suspects in the search for additional apoptotic roles
non-mammalian eukaryotes. As mammalian cells have been found to
die by potentially multiple mechanisms other than apoptosis, there is
a growing need to explore the cell death mechanisms of multiple
model organisms to develop a complete understanding of genetically
controlled cell suicide. In this review, we discuss the current research
on the role of mitochondria in programmed cell death in three non-
mammalian models, C. elegans, Drosophila and yeast. Understanding
the similarities and differences in these models will help identify the
conserved functions of mitochondria in cell death.
2. Cell death pathways in non-mammalian models: mitochondria
as a docking site
In C. elegans, most cell death events are under the control of the
central apoptotic pathway composed of the BH3-only protein EGL-1,
the Bcl-2-like protein CED-9, the Apaf-1-like protein CED-4, and the
caspase CED-3 [19]. In healthy cells, CED-9 sequesters CED-4 to
mitochondrial membranes [20–23]. In cells destined to die, binding of
EGL-1 to CED-9 disrupts its interaction with CED-4 [21,24,25].
Released CED-4 forms an octamer, translocates to perinuclear
membranes, and activates the processing of CED-3, thereby initiating
CED-3-dependent apoptosis [21,26–29] (Fig. 1B).
In addition to this ‘direct’ pathway of apoptosis induction, several
lines of evidence suggest the existence of an ‘indirect’ pathway
involving additional pro-apoptotic factors [30]. First, the inhibition of
cell death seen in a weak ced-3 loss-of-function mutation is enhanced
by the loss of ced-9 function [31]. Hence, CED-9 has both anti-
apoptotic and pro-apoptotic functions. In healthy cells, CED-9
sequesters CED-4, but in dying cells, CED-9 also has a pro-apoptotic
function, as well as non-apoptotic functions related to mitochondrial
dynamics (see Section 5). Second, some of the CED-4 protein localizes
to the perinuclear membranes at permissive temperature in a ced-9
temperature-sensitive mutant (ced-9 (n1653ts)) without causing
apoptosis [21]. Even though it cannot be excluded that the level of
perinuclear CED-4 in this mutant is below a pro-apoptotic threshold,
this experiment suggests that release of CED-4 from mitochondria is
not sufﬁcient to initiate apoptosis. This would leave a room for an
CED-4 activation step potentially analogous to Cyt-c activation of
mammalian Apaf-1 leading to caspase activation (see Section 4).
In Drosophila, the pro-apoptotic regulators Reaper (Rpr), Hid,
Grim, and Sickle (known collectively as RGH proteins) regulate
apoptosis [8,32–34]. These factors induce apoptosis by binding to the
Drosophila Inhibitor of Apoptosis Protein 1 (DIAP1), thereby inhibiting
DIAP1 function, and this is followed by the activation of the effector
caspases [16]. DIAP1 is the key anti-apoptotic molecule in Drosophila
that ensures cell survival by inhibiting caspase activity through direct
binding and/or by ubiquitylation of caspases and other pro-apoptotic
proteins [35]. Dronc, a CED-3/Caspase-9-like apical caspase, is
required for most developmental apoptosis [36]. Dronc associates
with the Apaf-1/CED-4-like protein Dark and becomes activated, in
turn activating the effector caspases [37–39]. Current models suggest
that Dronc activation is constitutive in most cells [17] (Fig. 1A).
Yeast are a more recent addition to the list of model organisms
used to study programmed cell death, and the topic of yeast cell death
remains at the fringes in both the cell death ﬁeld and the yeast
genetics ﬁeld. One of the hurdles to overcome in the study of yeast cell
death was the long-standing assumption that single-cell species have
no need of cell suicide pathways and, therefore, lack evolutionary
pressures to develop suchmechanisms. However, this notion has been
challenged and more recently overturned, in part due to revision of
evolutionary theories regarding group selection. The yeast cell death
ﬁeld was further challenged by the difﬁcult task of establishing
experimental models to compellingly demonstrate that yeast have a
purpose in dying in the absence of multicellular development.Nevertheless, several intriguing approaches have provided important
insight, including evidence that yeast cell death plays a role in
responding to viruses [40,41]. In addition, the relationship between
young and old yeast cells in a colony, which presumably reﬂects
physiologically relevant events in the environment, have revealed
that the death of old cells in a colony is essential to sustain younger
cells, and some of the genes and signaling molecules required for this
process have been identiﬁed [42,43]. Analogous studies in liquid
cultures have suggested that programmed cell suicide by a large
portion of the population ensures long-term survival of the species, as
cultures of cell death-resistant strains apparently consume the
dwindling nutrient supply and all cells ultimately die [44].
Deﬁnitions of programmed cell death and the cell death nomen-
clature applied to yeast cell death further contribute to the
controversies. For example, apoptosis has been applied to mean
programmed cell death in general but can strictly refer to caspase-
dependent cell death [45,46]. The existence of cell death pathways in
yeast that resemble in part mammalian cell death pathways is
supported by the fact that yeast encode several homologs of
mammalian cell death regulators, but they lack many others. Yeast
appear to lack the conserved caspase-activating apoptosome found in
mammals, ﬂies, and worms, as yeast lack both an Apaf-1-like factor
and a true caspase. However, yeast do encode a metacaspase Mca1/
Yca1 that is related to plant metacaspases and appears to contribute
importantly to yeast cell death induced by a multiple (but not all)
stimuli based on genetic studies [47]. It is unclear if this yeast
metacaspase, which lacks the Asp-cleaving activity characteristic of
caspases, might have additional caspase-like functions. Thus far, the
closest analogy is the identiﬁcation of a conserved protein in humans
(p100/SND1) and plants (TSN/Tudor staphylococcal nuclease) that is a
substrate of human caspase-3 and of a plantmetacaspase, respectively,
during cell death [48]. Yeast also lack sequence similarity to Bcl-2
family proteins, although the existence of structural or functional
equivalents in yeast cannot be ruled out. For example, several Bcl-2-
like viral proteins that lack amino acid sequence similarity to Bcl-2
have been identiﬁed by 3-dimensional structure determination (e.g., 9
different ORFs in the vaccine strain of vaccinia virus) [49]. Although
yeast lack recognizable homologs of the Drosophila IAP inhibitors
Reaper, Grim, and Hid, they do encode a protein containing an N-
terminal BIR domain analogous to IAP proteins. Yeast Bir1 has been
reported to protect yeast from cell death, but the detailedmechanisms
have not been delineated [50].
Despite the prominent differences between the molecular ma-
chinery of yeast cell death compared to other species, mounting
evidence supports the existence of gene-dependent death mechan-
isms in yeast. New evidence for the existence of potentially many
non-apoptotic cell death mechanisms in mammals increases the
likelihood that some of these pathways are represented in yeast. For
example, autophagy has been extensively studied in yeast, although
little is known about the role of autophagy in yeast cell death. Yeast as
a model system to study programmed cell death is still catching up to
ﬂies and worms, but these are early days.
In both ﬂies and worms, there is strong evidence for a role for
mitochondria as a docking site for proteins involved in cell death. In C.
elegans, the CED-9/CED-4 complex is localized to mitochondrial
membranes in healthy cells, and disruption of this complex by EGL-1
results in cell death [20–25]. In Drosophila, Rpr, Grim, and Hid have
been found to localize to mitochondria upon expression in Drosophila
S2 cells, and this localization is important for mitochondrial permea-
bilization and efﬁcient apoptosis activation [51–54]. The GH3 domain,
an amphipathic helix conserved between Grim, Rpr, and Skl, is
required for mitochondrial localization, possibly through associate
withHid,whichhas a hydrophobic C-terminalmitochondrial targeting
sequence [55]. In the absence of the Rpr GH3 domain, the IAP
inhibitory activity of Rpr is preserved, but killing activity and IAP
degradation are inhibited [52,53]. One possible interpretation of these
Fig. 1. (A) Mitochondria and apoptosis in Drosophila. Cell death in Drosophila is activated by Rpr, Hid, Grim, and Skl, which bind to DIAP1 and inhibit DIAP1's caspase inhibitory
function. The role of cytochrome c in Drosophila caspase activation is not well characterized; however, a role for the mitochondria in the apoptotic process is suggested by the several
ﬁndings, including Rpr, Grim, and Hid localization to the mitochondria. On initiation of apoptosis, Rpr and Hid are transcribed and rapidly localize to mitochondria, resulting in
changes in mitochondrial ultrastructure and Cyt-c release. Drp1-dependent mitochondrial disruption appears to be required for Drosophila apoptosis. Upon apoptosis induction,
dOmi is released into the cytosol, where it binds DIAP1 causing caspase activation. The role of Drosophila Bcl-2-like proteins Buffy and Debcl in ﬂy apoptosis remains unclear.
Additionally, despite a requirement of Dark for caspase activation, the role of Drosophila apoptosome in caspase activation is not well understood. (B) Mitochondria and apoptosis in
C. elegans. Two apoptotic pathways are at work in C. elegans. During apoptosis, the pro-apoptotic BH3-only protein EGL-1 binds to the anti-apoptotic Bcl-2-like protein CED-9,
thereby releasing the pro-apoptotic Apaf-1 like protein CED-4. Released CED-4 oligomerizes and promotes the processing of pro-caspase CED-3. CED-4 and active CED-3 form a
holoenzyme that triggers apoptosis (‘DIRECT’ pathway). In a parallel pathway, when bound to EGL-1, CED-9 adopts a pro-apoptotic conformation and activates the dynamin-related
protein DRP1. Active DRP1 promotes mitochondrial fragmentation and apoptosis by enhancing CED-3 processing or by acting in parallel to CED-3. The pro-apoptotic role of DRP1
could involve the release of potential pro-apoptotic factors (such as Cyt-c (CYC-2.1 or CYC-2.2) or an unknown factor X) but seems to be unrelated to its role in mitochondrial ﬁssion
(‘INDIRECT’ pathway). Later during apoptosis, the endonuclease CSP-6 and the AIF homologWAH-1 are released frommitochondria to degrade nuclear DNA, thereby participating in
the dismantlement of the cell.
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mitochondria [53,56]. Therefore, theGH3domain appears to be critical
for both Rpr mitochondrial localization and IAP destabilization. This
indicates that mitochondrial localization maybe important for Rpr
killing by DIAP1 destabilization, and not just DIAP1 inhibition [53]. In
yeast, the pro-death function of Dnm1 (Drp1) appears to occur at
mitochondria [57], and yeast AIF has been reported to translocate frommitochondria to the nucleus during death [58], but the subcellular
localization of most cell death regulators in yeast is not yet known.
3. The role of mitochondrial permeabilization
Mitochondrial outer membrane permeabilization (MOMP) has
been proposed as a “point of no return” of themitochondrial apoptotic
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stimuli that cause the release of Cyt-c and other pro-apoptotic
proteins from the intermembrane space of mitochondria into the
cytoplasm [59]. It is a rapid concerted process and affects most, if not
all, mitochondria and can occur in response to various stimuli and in
different cell types with or without caspase activity [60]. Unlike in C.
elegans, Bcl-2-family proteins in mammalian systems do not directly
regulate Apaf-1 but instead regulate (positively and negatively) the
earlier steps leading to release of Cyt-c from the mitochondria [61,62].
The role of the Drosophila Bcl-2 proteins in mitochondrial
permeabilization and cell death has not been yet fully characterized.
In Drosophila, there are two homologs of the Bcl-2/CED-9 family
proteins, Debcl/dBorg-1/dRob-1 and Buffy/dBorg-2 [63–65]. Both
Debcl and Buffy share the BH1, BH2, BH3, and C-terminal transmem-
brane domains of the Bcl-2 family of proteins [66,67]. Debcl has been
shown to localize to mitochondria, while Buffy localizes to the
endoplasmic reticulum [67]. Overexpression and knockdown studies
suggest that Debcl has a pro-apoptotic function [63,68,69] while Buffy
is antiapoptotic [70,71]. However, a recent study showed that loss of
Buffy can cause microchaete glial cell survival and blocks Grim
induced cell death in the eye, suggesting a pro-apoptotic role for Buffy
[72]. Moreover, Debcl has been suggested to protect against poly-
glutamine-induced death in the nervous system, which is antagonized
by Buffy expression [73]. This situation in ﬂies is potentially analogous
to the mammalian nervous system where pro-apoptotic mammalian
Bcl-2 proteins can exhibit potent anti-death activity [74,75]. Debcl
appears to have a limited role in Drosophila developmental apoptosis.
However, a recent study showed that Debcl can be effectively
recruited for killing by mammalian pro-apoptotic Bcl-2 gene family
members [68]. Debcl mutations appear to reduce irradiation-induced
cell death in the embryo [76], but they do not affect irradiation-
induced cell death in the wing, despite increased morphological
defects [68]. Gene disruption studies suggest that Debcl is required to
inhibit the antiapoptotic function of Buffy [76]. Surprisingly, loss of
Debcl does not appear to cause any defects in mitochondrial
organization in living cells or in mitochondrial fragmentation in
dying cells. In contrast, Buffy expression was shown to protect cells
from mitochondrial changes and apoptosis caused by loss of function
of Drosophila PTEN-induced kinase (Pink1) [71]. In summary,
controversies persist regarding the speciﬁc functions of ﬂy Bcl-2-like
proteins (Buffy and Debcl) in cell death. Additional functional studies
in vitro and in vivo are required to characterize the importance of
these proteins in Drosophila apoptosis.
Although further studiesmay demonstrate a role for theDrosophila
Bcl-2 proteins in regulating mitochondrial changes in apoptosis, it is
also possible that other proteins such as Rpr, Grim, and Hid have taken
over this function in ﬂies. Drosophila mitochondria are rapidly
permeabilized when Rpr or Hid are expressed, both in cultured S2
cells and in vivo [51]. Mitochondrial permeabilization was also seen
during DNA damage-induced apoptosis in ﬂy embryos. This permea-
bilization requires RHG gene function. These data indicate that Rpr
and Hid are both necessary and sufﬁcient for mitochondrial
permeabilization in Drosophila. Interestingly the GH3 domain of Rpr
and Grim appears to have a pro-apoptotic activity that is independent
of IAP inhibition and caspase activation, suggesting that this domain
might play a role in mitochondrial permeabilization and cell death
[52,77].
Little is known about mitochondrial permeabilization during C.
elegans apoptosis. The only protein shown to be released from
mitochondria in apoptotic cells is the AIF homolog, WAH-1 [78].
However, as discussed below, this release seems to be a late apoptotic
event. In addition, WAN-1, one of four adenine nucleotide transloca-
tors (ANT) in C. elegans, has been shown to have pro-apoptotic activity
[79]. Inmammals, ANT is thought to participate in the formation of the
Permeability Transition Pore (PTP) in the inner mitochondrial
membrane, although this is still under debate. The opening of thePTP during apoptosis has been proposed to cause mitochondrial
swelling, rupture of the outer mitochondrial membrane, and release
of pro-apoptotic factors localized in the inter membrane space [80].
Similarly, the mechanism by which WAN-1 exerts its pro-apoptotic
activity in C. elegans remains unclear. Surprisingly, WAN-1 has been
shown, by co-immunoprecipitation, to interact with CED-9 and CED-
4, and these interactions have been shown to be disrupted in the
presence of EGL-1 [79]. However, it is unclear how CED-9 and CED-4,
which are both localized on the surface of mitochondria, can interact
with an integral protein of the inner mitochondrial membrane. In
addition, there is no evidence that WAN-1 participates in the
permeabilization of C. elegans mitochondria during apoptosis. There-
fore, the role of WAN-1 in C. elegans apoptosis remains unclear.
In yeast, Cyt-c release from mitochondria during cell death has
been observed and suggested to promote cell death, but a causal role
is not ﬁrmly established [81,82]. Given the absence of BAX-related
proteins in yeast, the mechanism of Cyt-c release in yeast is unclear.
The conserved mitochondrial protein AAC/ANT (ADP/ATP carrier) has
been reported to be required for Cyt-c release in yeast and cell death
induced by acetic acid but not H2O2 [83]. Release of yeast Pep4,
homolog of mammalian cathepsin D, from vacuoles during yeast cell
death may play a role as well [84]. While intriguing, these events and
their role in executing the yeast cell death program have not been
fully investigated.
4. Release of pro-apoptotic factors from mitochondria
In mammals, the release of Cyt-c from intermembrane space of the
mitochondria into the cytoplasm occurs in response to a variety of
pro-apoptotic stimuli and is regulated by the Bcl-2 family proteins
[18,61,62]. Formation of the mammalian apoptosome, and subse-
quent caspase activation, requires Cyt-c binding to Apaf-1 [85].
Several keymitochondrial changes appear to be required for complete
Cyt-c release including changes in mitochondrial ultrastructure,
mitochondrial permeability, andmembrane potential [86]. In addition
to Cyt-c, proteins released from mitochondria during mammalian
apoptosis include apoptosis inducing factor (AIF), ARTS, SMAC/Diablo,
and Omi/HTRA2 [87–89].
In recent years, several lines of evidence have supported a role for
mitochondrial proteins inDrosophila apoptosis. Caspases inDrosophila
S2 cell extracts were shown to be activated by mitochondria from
apoptotic S2 cells, suggesting that mitochondrial factors contribute to
caspase activation [90]. By contrast, other studies, using cell-free
extracts, have found that mitochondrial lysates from apoptotic cells
are not able to induce or accelerate apoptosis in S2 extracts [91]. It is
important to note that these studies have used different apoptosis
inducers, for example, expression of exogenous pro-apoptotic
proteins vs. UV, which may have differing effects on mitochondria
[51].
Whether Cyt-c is released from mitochondria in Drosophila
apoptosis has also been a source of controversy. Earlier studies by
Varkey et al. reported exposure of a Cyt-c epitope in apoptotic cells
[90]. However, this epitope remains punctate, and the data were
interpreted to suggest that Cyt-C was still localized to mitochondria.
However, newer studies demonstrate that Cyt-c becomes rapidly
diffuse in dying cells [51]. These differences may be due to alterations
in the antibody staining procedure or differences in antibody epitopes.
Subcellular fractionation studies have also provided conﬂicting
evidence for Cyt-c release [37,51,90,92–94]. Again, these apparent
contradictions may be due to technical differences. Nevertheless,
unlike mammalian cells, studies in Drosophila indicate that Cyt-c
release is not the easily detectable indicator of apoptosis initiation in
ﬂies.
In mammals, knock-in experiments demonstrate a pro-apoptotic
role for Cyt-c in some, but not all, developmental apoptosis [95].
Numerous studies using tissue culture cells did not detect any role for
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demonstrate a role for Cyt-c in some developmentally important
caspase activation. Mutation of one of the two Cyt-c genes, cyt-c-d,
and loss of function of the Apaf-1 homolog Dark were found to cause a
disruption of caspase-dependent spermatid individualization, sug-
gesting that Dark and cyt-c-d might act together in caspase activation
in these cells, similar to the prevailing models for Apaf-1 and Cyt-c in
mammals [97–99]. Interommatidial cell death in the developing ﬂy
eye is also suppressed by lack of cyt-c-d, as well as by Dark mutation
[100]. Moreover, adult ﬂies lacking cyt-c-d also show an extra
scutellar bristle, another phenotype that is observed in Dark mutants.
Thus, in Drosophila, Cyt-c is apparently important for some apopto-
some-dependent caspase activation. Interestingly, similar to mam-
malian Apaf-1, Drosophila Dark contains the WD40 regulatory region
that binds to Cyt-c. However, structural characterization of the
Drosophila apoptosome showed that although DarkWD40 region is
important for Cyt-c binding, Drosophila apoptosome formation does
not appear to require Cyt-c and forms spontaneously with recombi-
nant proteins in vitro and without additional co-factors [101].
However, structural studies may not reﬂect the active form of the
proteins, so these data should be interpreted with some caution.
Studies in other insect models could facilitate understanding of the
role of mitochondrial proteins in cell death. A recent study in
Lepidopteran sf9 cells identiﬁed an important role for cytochrome c
in apoptosis and provided evidence for PTP-independent Cyt-c release
in sf9 cells [102]. Caspase activation in sf9 cell extracts was found to be
exclusively dependent on Cyt-c release.
The mammalian pro-apoptotic proteins Smac/Diablo, ARTS, and
Omi/HTRA2 are released from the mitochondria into the cytoplasm in
dying cells, with kinetics similar to that of Cyt-c. These pro-apoptotic
proteins can then bind to XIAP, an IAP protein, thereby preventing
XIAP from inhibiting caspases [103]. SMAC/Diablo is a putative
functional ortholog of the Drosophila RHG proteins. However,
activation of SMAC/Diablo activity by release from mitochondria is
quite different from the mechanism of activation of the Drosophila IAP
inhibitors, which are for the most part transcriptionally upregulated
in doomed cells [104].
The mammalian IAP antagonist, Omi/HtrA2, is constitutively
expressed and sequestered to the mitochondrial intermembrane
space before mitochondrial permeabilization [105,106]. It contains
both IAP binding and serine protease activities and exerts its pro-
apoptotic function through binding and cleavage of IAPs upon its
release into the cytoplasm following a pro-apoptotic stimulus. In
Drosophila, the homolog of this protein, dOmi, was recently described
[94,107]. Upon cellular insults such as UV irradiation, Drosophila dOmi
is released from the mitochondria and alleviates DIAP1 inhibition of
caspases by proteolytically degrading DIAP1. dOmi induces apoptosis
both in cultured cells and in the developing ﬂy eye [94,108].
Mammalian cell death induced by Omi overexpression can also
occur under caspase inhibiting conditions and in Apaf-1 and Caspase-
9 null cells [105,106]. dOmi also has a caspase-independent pro-
apoptotic activity dependent on its serine protease activity [94,108].
Interestingly, knockdown of dOmi was found to inhibit stress-induced
apoptosis in the ﬂy [107], in contrast to knockout mice lacking HtrA2/
Omi, which shows increased stress-induced apoptosis and neurode-
generation [109].
Apoptosis-inducing factor (AIF) is another mitochondrial protein
released during death. AIF can translocate to the nucleus following an
apoptotic stimulus and triggers DNA degradation and chromatin
condensation in mammals [110]. AIF is one of several related
oxidoreductase-like factors encoded from mammals to yeast. Mam-
malian AIF has dual functions, a pro-apoptotic activity in the nucleus
via its DNA binding and an anti-apoptotic activity via the scavenging
of free radicals through its oxidoreductase activity [111]. Similarly,
knockout of the Drosophila homolog of AIF suggests both pro-survival
and pro-apoptotic functions for this protein [112]. Drosophila AIFknockout causes lethality at early larval stages, with reduced ATP and
reduced apoptosis in the developing embryo. Expression of a
truncated AIF induced cell death in the eye; however, this phenotype
was suppressed by DIAP1 or DIAP2, suggesting that AIF induces cell
death through a caspase-dependent mechanism, either directly or
indirectly through stress pathways.
Even though apoptosis-related mitochondrial permeabilization is
not well understood in C. elegans, several mitochondrial proteins,
including WAH-1 and CPS-6, as well as CYC-2.1 and CYC-2.2, the two
cytochromes c of C. elegans, are good candidates for pro-apoptotic
factors released frommitochondria during apoptosis. Mutation in the C.
elegans cps-6 gene, which encodes the homolog of the mammalian
endonuclease G (endoG), causes a delay in apoptosis in C. elegans [113].
Interestingly, CPS-6 has been shown to cooperate with WAH-1, the
homolog of the mammalian apoptosis inducing factor (AIF) to degrade
nuclearDNA [78]. These twoproteins localize tomitochondria.Whereas
it has not been determined whether CPS-6 is released from mitochon-
dria during apoptosis, it has been shown that EGL-1 can induce the
release of WAH-1 from mitochondria [78]. The mechanism by which
WAH-1 is released is currently unknown. However, it is thought to be
dependent on the activity of the caspase CED-3, and hence represents a
late event that occurs after the cell has committed to die.
How cytochrome c might function in C. elegans apoptosis remains
unclear. Unlike Apaf-1 in mammals and Dark in Drosophila, CED-4
does not contain a WD40 repeat domain, which is responsible for the
binding of Cyt-c to Apaf-1. It has therefore always been assumed that
Cyt-c does not bind to CED-4 and does not play a role in C. elegans
apoptosis. In fact, a high-resolution structural study of the CED-4
apoptosome was recently reported [29]. The CED-4 apoptosome is a
cone-shaped octamer, a fundamentally different structure than the ﬂy
or mammalian apoptosome. To our knowledge, it has not been tested
whether inactivating the cyc-2.1 and/or cyc-2.2 gene compromises
apoptosis, whether the CYC-2.1 and/or CYC-2.2 proteins are released
from mitochondria during apoptosis, whether they bind to CED-4 (by
a mechanism different from the one discovered in mammals), or
whether they can enhance CED-4-induced CED-3 processing. In
conclusion, more experiments need to be done to determine whether
Cyt-c play a role in C. elegans apoptosis or not.
Whereas two homologs of the inhibitor of apoptosis proteins (IAP)
exist in C. elegans (BIR-1 and BIR-2), neither of them play a role in
apoptosis [114]. It is therefore not surprising that no homologs of the
pro-apoptotic factors Smac/DIABLO and Omi/Htra2 have been
identiﬁed in C. elegans. However, it remains possible that other
mitochondrial proteins play a pro-apoptotic role in C. elegans. These
proteins might not have been identiﬁed yet if they support an
essential mitochondrial function and cause early embryonic lethality
when inactivated.
The yeast Saccharomyces cerevisiae encodes homologs of AIF and
Htra2/Omi, and these factors have been implicated in promoting cell
death. Yeast Aif1 (YNR047C), an NADH oxidoreductase, was named
after its mammalian ortholog AIF (apoptosis inducing factor).
Translocation of yeast Aif1 from mitochondria to the nucleus is
suggested to degrade DNA and promote yeast cell death, which is
supported by the ﬁnding that AIF1 gene deletion leads to increased
survival [58]. The Aif1-related yeast protein Ndi1 (internal NADH
dehydrogenase), but not the related protein Nde1 (external NADH
dehydrogenase), is reported to promote yeast cell death when
overexpressed, but deletion of either gene increases chronological
lifespan [115]. In contrast, expression of yeast Ndi1 in Drosophila
neurons was recently reported by two groups to increase Drosophila
lifespan [116,117], and there is interest in exploring the potential
application of this single chain NADH-quinone oxidoreductase to the
treatment of complex I deﬁciencies in Parkinson's disease [118].
While yeast Ndi1 may contribute importantly to yeast cell death, a
physiological or evolutionary role in yeast programmed cell death is
challenging to prove.
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ortholog of four mammalian mitochondrial serine proteases including
Htra2/Omi. Deletion of the NMA111 gene increases yeast survival
following heat shock treatment, while overexpression of Nma111
promotes death in a manner that requires its serine protease activity
[119]. Further information about the substrates of the Nma111
protease or how cleavage of these substrates promotes death would
help to conﬁrm the importance of Nma111 in programmed yeast
death. The yeast mitochondrial nuclease Nuc1, ortholog of the pro-
death nuclease EndoG, also may promote death in yeast [120].
5. Alterations in mitochondrial morphology and structure
Mitochondria are highly dynamic organelles that undergo ﬁssion
and fusion in living cells, with shapes ranging from short isolated
organelles to interconnected networks [121]. Morphological changes
at the level of single mitochondria, as well as changes in the dynamics
of mitochondrial ﬁssion and fusion, are associated with cell death
[122].
In mammals, mitochondrial ﬁssion requires several proteins
including dynamin-related protein 1 (DRP1/DLP1), Fis1, endophilin
B1/Bif-1, MTP18, GDAP1, and DAP3 [123–132]. On the other hand,
fusion requires three large GTPases: the mitofusins (Mfns) Mfn1 and
Mfn2, and the dynamin-related protein OPA1 [133–136]. Mitochon-
drial fragmentation has been shown to increase signiﬁcantly during
programmed cell death in mammals, yeast, worms, and ﬂies
[57,68,137–139]. Overexpression of a dominant negative DRP1 or
knockdown of DRP1 with RNAi or mutation results in decrease
mitochondrial fragmentation after apoptosis induction in all four
model systems [68,137–140].
Interestingly, mitochondrial fragmentation in mammalian cells is
associated with permeability of the outer mitochondrial membrane
(MOMP), a hallmark of apoptosis [141–143]. Mitochondrial swelling
is one likely mechanism by which pro-apoptotic proteins are released
in response to the permeabilization of the outer mitochondrial
membrane and can be observed in ﬂy cells as well as in mammalian
cells [51,144]. In mammals, MOMP can occur in a caspase-indepen-
dent fashion [145], or in a caspase-dependent fashion [146], although
there is some controversy in this regard.
Upon apoptotic stimulation, ultrastructural changes, such as
swelling, can be detected in both mammalian and Drosophila cells
[51,147]. Interestingly, apoptosis induced by expression of Reaper or
Hid causes caspase-dependent changes in the mitochondrial ultra-
structure [51]. DRP1 inhibition results in mitochondrial fusion and
signiﬁcantly inhibits caspase activation and apoptosis in ﬂies [51],
while it delays caspase activation in mammals [148]. One possibility is
that the ﬁssion machinery may contribute to mitochondrial mem-
brane permeabilization and release of pro-apoptotic factors [122].
Another explanation is that sites of mitochondrial ﬁssion might serve
as scaffolding for the localization of other pro-apoptotic proteins, as
seen with Bax in mammalian systems [149]. It is also possible that
DRP1 has a role in apoptosis independent of its role in mitochondrial
dynamics [139].
In C. elegans, mitochondrial fusion and ﬁssion are under the control
of these GTPases. FZO-1 and EAT-3, the homologs of mammalian
mitofusin and Opa1, are required for the fusion of the outer and inner
mitochondrial membranes, respectively [150–152]. On the other
hand, DRP1, the homolog of mammalian DRP1/DLP1, is required for
mitochondrial ﬁssion [153]. Jagasia et al. showed that mitochondria
undergo DRP1-dependent excessive ﬁssion (a process referred to
hereafter as ‘mitochondrial fragmentation’) early during the apoptotic
process [139]. Interestingly, blocking mitochondrial fragmentation by
overexpressing a dominant negative DRP1 protein (DRP1(K40A))
prevents the death of 20% of the cells that are normally programmed
to die. Conversely, inducing mitochondrial fragmentation by over-
expressing a wild-type DRP1 protein causes the death of cells, whichare normally programmed to survive. Consistent with these results,
Breckenridge et al. showed that drp-1 loss-of-function mutation (drp-
1(tm1108)) enhances the partial block in cell death caused by a weak
ced-3 or ced-4 loss-of-function mutation [152] [Y Lu, B. Conradt,
unpublished observation]. Together, these studies demonstrate that C.
elegans DRP1 has pro-apoptotic activity. However, whether DRP1's
pro-apoptotic activity is related to its ability to cause mitochondrial
ﬁssion remains unclear. If the mitochondrial fragmentation process
per se is required for apoptosis induction, one would expect that
blocking mitochondrial fusion causes the same ectopic cell death as
observed when inducing mitochondrial fragmentation. In contrast,
mutants carrying a loss-of-function mutation in the gene fzo-1 do not
show any increase in cell death despite a clear mitochondrial
fragmentation phenotype [152]. Similarly, the loss of eat-3 function
causes mitochondrial fragmentation but no apparent cell death
phenotype [150]. These observations point toward a role of DRP1 in
apoptosis independent of its role in mitochondrial ﬁssion. However,
the analysis of the latter worm mutations has so far been focused on
developmental cell death. In mammals, blocking mitochondrial fusion
by inactivating mitofusin does not cause increased apoptosis on its
own but sensitizes cells to external apoptotic stimuli [154]. Therefore,
to completely rule out a role for mitochondrial fusion proteins in C.
elegans apoptosis and consequently rule out a role for the ﬁssion
activity of DRP1 in apoptosis, it will be necessary to test the effect of
external apoptotic stimuli (such as radiation on germ cell death) in
mitochondrial fusion defective mutants.
Interestingly, Jagasia et al. showed in C. elegans that the DRP1-
dependent mitochondrial fragmentation in apoptotic cells is depen-
dent on CED-9 and EGL-1 [139]. Two apoptotic pathways might
therefore be at work in C. elegans (Fig. 1B) [30]. On one hand, the
binding of EGL-1 to CED-9 causes the release of CED-4, leading to the
activation of CED-3 (‘direct’ pathway of apoptosis induction). On the
other hand, when bound to EGL-1, CED-9 adopts a pro-apoptotic
conformation and stimulates the pro-apoptotic activity of DRP1
through a mechanism that remains to be determined (‘indirect’
pathway of apoptosis induction). Recent work shows that Bcl-2-like
proteins can interact with and regulate dynamin-related GTPases
[155–159]. Speciﬁcally, in C. elegans, CED-9 has been shown to
interact with FZO-1 and to promote mitochondrial fusion in healthy
cells [157]. Therefore, one possible mechanism is that EGL-1-bound
CED-9 directly interacts with and activates DRP1 in dying cells.
Yeast mitochondria, like in other species, undergo dramatic
organelle fragmentation during programmed cell death
[140,160,161]. This fragmentation is mediated in part by the yeast
homolog of DRP1, Dnm1, and an additional yeast ﬁssion factor for
which human/ﬂy/worm orthologs are not known, Mdv1. This WD40
repeat protein is suggested to facilitate the interaction of Dnm1 with
the conserved membrane-anchored Fis1 protein [57,162,163]. Like
other species, Dnm1/Drp1 also promotes yeast cell death because
deletion of the DNM1 gene in yeast results in increased survival
following a death stimulus, even though this deletion strain grows
essentially indistinguishably from wild type under normal condi-
tions [57]. Because Dnm1 deletion strains are resistant to several
different death stimuli (including heat, acidic pH, and H2O2), Dnm1
appears to be a common downstream effector of cell death.
Overexpression of Dnm1 does not appear to be sufﬁcient to kill
yeast, but further addition of a death stimulus, which is apparently
required to activate the death function of Dnm1, leads to a striking
increase in cell death that can be inhibited bymammalian Bcl-2 family
proteins [57]. Also similar to other species, a dominant negative Dnm1
that inhibits yeast mitochondrial ﬁssion also protects yeast from cell
death.
The yeast cell death mediated by endogenous or overexpressed
Dnm1 is partially dependent on the metacaspase Yca1/Mca1, which
has distant amino acid sequence similarity to mammalian/worm/ﬂy
caspases, but is more closely related to bacterial proteases [164]. Yca1
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death stimuli, including yeast killer viruses, but neither Yca1 nor yeast
Aif1 contributes to cell death that occurs by ammonia-dependent
signaling and quorum sensing [40,47,165,166]. Yca1 apparently does
not cleave after aspartate residues and therefore does not conform to
the deﬁnition of a c-asp-ase so strictly adhered to by true caspases,
suggesting that alternative non-apoptotic death mechanisms may be
involved [167]. The mechanism by which Yca1 mediates yeast cell
death is not yet delineated.
Although Fis1 can promote mitochondrial ﬁssion and cell death in
mammals, the yeast deletion strain is exquisitely sensitive to all cell
death stimuli tested thus far. However, this death phenotype is not
due to the loss of FIS1 function, at least not directly. Whole genome
sequencing identiﬁed secondary mutations in three independently
derived FIS1 knockout strains, each with a unique inactivating
nonsense mutation in WHI2, and this mutation in WHI2 is solely
responsible for the cell death phenotype [168]. The hypothesis that
deletion of FIS1 is sufﬁcient to drive the selection for WHI2 mutations
is supported by the ﬁnding that FIS1-only knockouts have a
mitochondrial defect resulting in petite formation (presumed loss of
respiratory capacity) that is rescued by the WHI2 mutation [168].
However, the cell death inhibitory function of WHI2 is uncharacter-
ized. It is further possible that many other single gene deletions in
yeast (and other species) will drive the selection for compensatory
mutations that provide small growth and survival advantages and
that these have gone unnoticed thus far because programmed cell
death is still not a mainstream topic in yeast genetics.
6. Non-mammalian models of human diseases
Mutations in PINK1, a mitochondrial Ser/Thr kinase, and Parkin, an
E3 ubiquitin ligase, were identiﬁed as a cause of familial Parkinson's
disease. In Drosophila, Pink1 mutation leads to defects in spermatid
individualization, progressive apoptotic death of ﬂight muscles
[71,169,170] and loss of dopaminergic neurons [71,170]. Pink1
accumulation on mitochondria was shown to be important for Parkin
recruitment to mitochondria [171]. Interestingly, Parkin was found to
be involved in targeting of mitochondria to autophagosomes and
mitophagy [172]. Tissue-speciﬁc phenotypes observed in Drosophila
parkin mutants may result from mitochondrial dysfunction [173].
Moreover, Pink1 or Parkin mutants were found to closely interact
with the regulators of mitochondrial ﬁssion and fusion in Drosophila.
For example, expression of DRP1 or knockdown of Drosophila MFN
(dMfn or MARF) or Opa1 suppresses Pink1 and Parkin phenotypes.
Loss of one copy of DRP1 is lethal in Pink1 and parkin mutant
backgrounds [174]. dMfn ubiquitination was suggested to be a
mechanism by which terminally damaged mitochondria are labeled
and sequestered for degradation by autophagy [175].
Parkinson's disease has also been associated with point mutations
in HtrA2/Omi, and the phosphorylation of HtrA2/Omi was reduced in
patients with a PINK1 mutation. In Drosophila, dOmi has been
reported to interact with Pink1 or Parkin [176], and loss of dOmi
can partially suppress phenotypic changes caused by PINK1 over-
expression. In Omi/HtrA2 knockout mouse embryonic ﬁbroblasts, as
well as in Omi/HtrA2 silenced human HeLa cells and Drosophila S2R+
cells have elongated mitochondria and abnormal cristae struc-
ture [177]. Moreover, PINK1 overexpression can cause a rough eye
phenotype that is suppressed by loss of both dOmi and Parkin. These
observations contradict a previous report where loss of dOmi did not
cause mitochondrial defects and did not suppress Pink1 overexpres-
sion phenotypes [176]. Further investigations are required to clarify
this contradiction.
Mutation in the leucine-rich repeat kinase 2 (LRRK2) gene,
currently recognized as the one of the most common genetic players
involved in Parkinsonism, was shown to contribute to speciﬁc
neurological disorders. Overexpressing various human LRRK2 allelesin ﬂies causes late-onset loss of dopaminergic neurons accompanied
by locomotion deﬁcits. Importantly, coexpression of human parkin in
LRRK2 G2019S-expressing ﬂies signiﬁcantly protected against neuro-
degeneration [178].
The Drosophila gene CG4589 is the ortholog of LETM1, a candidate
gene for the haplo-insufﬁciency seizure phenotype of Wolf-Hirsch-
horn syndrome (WHS) patients. LETM is required for normal
mitochondrial morphology and cell viability [179]. Using RNAi
approaches in both Drosophila cultured cells and the adult ﬂy,
depletion of DmLETM1 caused roughening of the adult eye,
mitochondrial swelling, and developmental lethality in third-instar
larvae, possibly as a result of deregulated mitophagy [180].
LRK-1 and PINK-1, the C. elegans homologs of the two Parkinson
disease-related kinases LRRK2 and PINK1, have been shown to play
roles in oxidative and ER stress responses as well as neurite outgrowth
[181]. A recent study also showed that overexpression of lrk-1
transgenes carrying Parkinson's-disease-associated mutations in C.
elegans dopaminergic neurons caused age-dependent neurodegen-
eration and locomotion defects [182].
Exploitation of yeast as a model system has laid the groundwork
for subsequent work on a wide range of human disease genes related
to mitochondrial disorders [183,184], metabolic disorders [185–187],
aging [188,189], neurodegeneration [190,191], and cancer [192], often
leading to major new lines of research. Perhaps the most unexpected
application of yeast genetics is in the study of neurodegeneration,
where yeast have contributed importantly to our understanding of the
mechanisms of protein misfolding and aggregation common to
Huntington's disease (HD), Parkinson's disease (PD), and Alzheimer's
disease (AD) [193–195]. The analysis of human alpha-synuclein in
yeast revealed vesicle trafﬁcking defects and mitochondrial dysfunc-
tion as potential mechanisms involved in the neurodegenerative
effects of alpha-synuclein in Parkinson's disease. A small molecule
screen using this model system has recently identiﬁed a class of small
molecules that signiﬁcantly inhibits the toxic effects of alpha-
synuclein on vesicle trafﬁcking and mitochondria in both yeast and
neurons [196]. The identiﬁcation and function of mitochondrial ﬁssion
and fusion factors in ﬂies and yeast were instrumental to advance-
ments in understanding the mitochondrial defects caused by muta-
tions in their human homologsMFN2 (yeast FZO1) that cause Charcot-
Marie-Tooth (CMT) subtype 2A, and OPA1 (yeast MGM1) that causes
autosomal dominant optic atrophy (ADOA) [163]. Yeast are being
applied to the study of multiple additional human neurological
disease genes, such as FRDA (yeast YFH1), the cause of Friedreich
ataxia [197], Batten disease caused by mutations in human BAN1
(yeast CLN3) [198,199], Niemann-Pick disease caused by a mutation
in NPC1 (yeast NCR1) [200,201], as well as SOD1 in ALS [202], SPG7
(yeast AFG3 and RCA1) in hereditary spastic paraplegia (HSP) [203],
ABCD1 (yeast PXA1/2) in X-linked adrenoleukodystrophy (ALD)
[204], and many more. However, few have yet exploited yeast for
studying programmed cell death related to cancer or other human
disorders.
7. Conclusions and future prospects
In sum, many conserved mechanisms for mitochondrial involve-
ment in apoptosis have been proposed in non-mammalian eukar-
yotes. Mitochondrial permeabilization has been suggested to occur in
both ﬂies and yeast; however, this ﬁnding is still under discussion, and
the role of the released Cyt-c in apoptosis in these non-mammalian
models remains unclear. Recently, involvement of fusion and ﬁssion
proteins in the mitochondrial pathway of cell death appears to be a
more conserved event between mammals, ﬂies, worms, and yeast.
Moreover, mitochondrial fragmentation has been documented to be a
feature of mammalian and non-mammalian eukaryotic apoptosis. The
incomplete state of our knowledge of the mitochondrial death
pathways may explain the differences between various species.
604 E. Abdelwahid et al. / Biochimica et Biophysica Acta 1813 (2011) 597–607Thus, more genetic and biochemical analysis might clarify the
sophisticated mitochondrial mechanisms regulating the decision
whether a eukaryotic cell lives or dies. In addition, the non-
mammalian eukaryotes have been shown to be useful models to
understand the mechanisms of human disease as they relate to the
mitochondrial pathway of cell death. Thus, continued research into
the mitochondrial contribution to cell death in model organisms is
likely to provide important insight in the future.
Acknowledgments
The authors are supported by NIH grants GM55568 (K.W.),
GM076651 (B.C.), GM077875 (J.M.H.), ACS grant RSG-06-110-1-CCG
(B.C.), and MGH Fund for Medical Discovery (E.A.).
References
[1] J. Yuan, S. Shaham, S. Ledoux, H.M. Ellis, H.R. Horvitz, The C. elegans cell death
gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-
converting enzyme, Cell 75 (1993) 641–652.
[2] M. Miura, H. Zhu, R. Rotello, E.A. Hartwieg, J. Yuan, Induction of apoptosis in
ﬁbroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C.
elegans cell death gene ced-3, Cell 75 (1993) 653–660.
[3] M.O. Hengartner, H.R. Horvitz, C. elegans cell survival gene ced-9 encodes a
functional homolog of the mammalian proto-oncogene bcl-2, Cell 76 (1994)
665–676.
[4] N.E. Crook, R.J. Clem, L.K. Miller, An apoptosis-inhibiting baculovirus gene with a
zinc ﬁnger-like motif, J. Virol. 67 (1993) 2168–2174.
[5] B.A. Hay, D.A. Wassarman, G.M. Rubin, Drosophila homologs of baculovirus
inhibitor of apoptosis proteins function to block cell death, Cell 83 (1995)
1253–1262.
[6] M. Rothe, M.G. Pan, W.J. Henzel, T.M. Ayres, D.V. Goeddel, The TNFR2-TRAF
signaling complex contains two novel proteins related to baculoviral inhibitor of
apoptosis proteins, Cell 83 (1995) 1243–1252.
[7] Q.L. Deveraux, J.C. Reed, IAP family proteins—suppressors of apoptosis, Genes
Dev. 13 (1999) 239–252.
[8] K. White, M.E. Grether, J.M. Abrams, L. Young, K. Farrell, H. Steller, Genetic
control of programmed cell death in Drosophila, Science 264 (1994) 677–683.
[9] D. Vucic, W.J. Kaiser, A.J. Harvey, L.K. Miller, Inhibition of reaper-induced
apoptosis by interaction with inhibitor of apoptosis proteins (IAPs), Proc. Natl.
Acad. Sci. U. S. A. 94 (1997) 10183–10188.
[10] S.L. Wang, C.J. Hawkins, S.J. Yoo, H.A. Muller, B.A. Hay, The Drosophila caspase
inhibitor DIAP1 is essential for cell survival and is negatively regulated by HID,
Cell 98 (1999) 453–463.
[11] S. Lisi, I. Mazzon, K. White, Diverse domains of THREAD/DIAP1 are required to
inhibit apoptosis induced by REAPER and HID in Drosophila, Genetics 154 (2000)
669–678.
[12] L. Goyal, K. McCall, J. Agapite, E. Hartwieg, H. Steller, Induction of apoptosis by
Drosophila reaper, hid and grim through inhibition of IAP function, EMBO J. 19
(2000) 589–597.
[13] T. Kanki, D.J. Klionsky, The molecular mechanism of mitochondria autophagy in
yeast, Mol. Microbiol. 75 (2010) 795–800.
[14] B. Levine, G. Kroemer, Autophagy in the pathogenesis of disease, Cell 132 (2008)
27–42.
[15] E.H. Baehrecke, Autophagy: dual roles in life and death? Nat. Rev. Mol. Cell Biol. 6
(2005) 505–510.
[16] S. Kornbluth, K. White, Apoptosis in Drosophila: neither ﬁsh nor fowl (nor man,
nor worm), J. Cell Sci. 118 (2005) 1779–1787.
[17] B.A. Hay, M. Guo, Caspase-dependent cell death in Drosophila, Annu. Rev. Cell
Dev. Biol. 22 (2006) 623–650.
[18] D.R. Green, J.C. Reed, Mitochondria and apoptosis, Science 281 (1998)
1309–1312.
[19] H.R. Horvitz, Worms, Life, and Death (Nobel Lecture), Chembiochem 4 (2003)
697–711.
[20] A.M. Chinnaiyan, K. O'Rourke, B.R. Lane, V.M., Dixit, interaction of CED-4 with
CED-3 and CED-9: a molecular framework for cell death, Science 275 (1997)
1122–1126.
[21] F. Chen, B.M. Hersh, B. Conradt, Z. Zhou, D. Riemer, Y. Gruenbaum, H.R. Horvitz,
Translocation of C. elegans CED-4 to nuclear membranes during programmed cell
death, Science 287 (2000) 1485–1489.
[22] D. Wu, H.D. Wallen, G. Nunez, Interaction and regulation of subcellular
localization of CED-4 by CED-9, Science 275 (1997) 1126–1129.
[23] M.S. Spector, S. Desnoyers, D.J. Hoeppner, M.O. Hengartner, Interaction between
the C. elegans cell-death regulators CED-9 and CED-4, Nature 385 (1997)
653–656.
[24] B. Conradt, H.R. Horvitz, The C. elegans protein EGL-1 is required for programmed
cell death and interacts with the Bcl-2-like protein CED-9, Cell 93 (1998)
519–529.
[25] L. del Peso, V.M. Gonzalez, G. Nunez, Caenorhabditis elegans EGL-1 disrupts the
interaction of CED-9 with CED-4 and promotes CED-3 activation, J. Biol. Chem.
273 (1998) 33495–33500.[26] A.M. Chinnaiyan, D. Chaudhary, K. O'Rourke, E.V. Koonin, V.M. Dixit, Role of CED-
4 in the activation of CED-3, Nature 388 (1997) 728–729.
[27] S. Seshagiri, L.K. Miller, Caenorhabditis elegans CED-4 stimulates CED-3
processing and CED-3-induced apoptosis, Curr. Biol. 7 (1997) 455–460.
[28] N. Yan, J. Chai, E.S. Lee, L. Gu, Q. Liu, J. He, J.W. Wu, D. Kokel, H. Li, Q. Hao, D. Xue,
Y. Shi, Structure of the CED-4–CED-9 complex provides insights into
programmed cell death in Caenorhabditis elegans, Nature 437 (2005) 831–837.
[29] S. Qi, Y. Pang, Q. Hu, Q. Liu, H. Li, Y. Zhou, T. He, Q. Liang, Y. Liu, X. Yuan, G. Luo, H.
Li, J. Wang, N. Yan, Y. Shi, 2010. Crystal structure of the Caenorhabditis elegans
apoptosome reveals an octameric assembly of CED-4, Cell 141 (2010) 446–457.
[30] S. Rolland, B. Conradt, The role of mitochondria in apoptosis induction in
Caenorhabditis elegans: more than just innocent bystanders? Cell Death Differ. 13
(2006) 1281–1286.
[31] M.O. Hengartner, H.R. Horvitz, Activation of C. elegans cell death protein CED-9
by an ammo-acid substitution in a domain conserved in Bcl-2, Nature 369
(1994).
[32] P. Chen, W. Nordstrom, B. Gish, J.M. Abrams, grim, A novel cell death gene in
Drosophila, Genes Dev. 10 (1996) 1773–1782.
[33] A. Christich, S. Kauppila, P. Chen, N. Sogame, S.I. Ho, J.M. Abrams, The damage-
responsive Drosophila gene sickle encodes a novel IAP binding protein similar to
but distinct from reaper, grim, and hid, Curr. Biol. 12 (2002) 137–140.
[34] M.E. Grether, J.M. Abrams, J. Agapite, K. White, H. Steller, The head involution
defective gene of Drosophila melanogaster functions in programmed cell death,
Genes Dev. 9 (1995) 1694–1708.
[35] M.X. O'Riordan, L.D. Bauler, F.L. Scott, C.S. Duckett, Inhibitor of apoptosis proteins
in eukaryotic evolution and development: a model of thematic conservation,
Dev. Cell. 15 (2008) 497–508.
[36] D. Xu, Y. Li, M. Arcaro, M. Lackey, A. Bergmann, The CARD-carrying caspase Dronc
is essential for most, but not all, developmental cell death in Drosophila,
Development 132 (2005) 2125–2134.
[37] H. Kanuka, K. Sawamoto, N. Inohara, K. Matsuno, H. Okano, M. Miura, Control of
the cell death pathway by Dapaf-1, a Drosophila Apaf-1/CED-4-related caspase
activator, Mol. Cell 4 (1999) 757–769.
[38] A. Rodriguez, H. Oliver, H. Zou, P. Chen, X. Wang, J.M. Abrams, Dark is a
Drosophila homologue of Apaf-1/CED-4 and functions in an evolutionarily
conserved death pathway, Nat. Cell Biol. 1 (1999) 272–279.
[39] L. Zhou, Z. Song, J. Tittel, H. Steller, HAC-1, a Drosophila homolog of APAF-1 and
CED-4 functions in developmental and radiation-induced apoptosis, Mol. Cell 4
(1999) 745–755.
[40] I. Ivanovska, J.M. Hardwick, Viruses activate a genetically conserved cell death
pathway in a unicellular organism, J. Cell Biol. 170 (2005) 391–399.
[41] F. Breinig, T. Sendzik, K. Eisfeld, M.J. Schmitt, Dissecting toxin immunity in virus-
infected killer yeast uncovers an intrinsic strategy of self-protection, Proc. Natl.
Acad. Sci. U. S. A. 103 (2006) 3810–3815.
[42] M. Cap, L. Vachova, Z. Palkova, Yeast colony survival depends on metabolic
adaptation and cell differentiation rather than on stress defense, J. Biol. Chem.
284 (2009) 32572–32581.
[43] Z. Palkova, L. Vachova, Life within a community: beneﬁt to yeast long-term
survival, FEMS Microbiol. Rev. 30 (2006) 806–824.
[44] V.D. Longo, J. Mitteldorf, V.P. Skulachev, Programmed and altruistic ageing, Nat.
Rev. Genet. 6 (2005) 866–872.
[45] J.C. Ameisen, On the origin, evolution, and nature of programmed cell death: a
timeline of four billion years, Cell Death Differ. 9 (2002) 367–393.
[46] M.E. Borello, The rise, fall and resurrection of group selection, Endvour 29 (2005)
43–47.
[47] F. Madeo, E. Herker, C. Maldener, S. Wissing, S. Lachelt, M. Herlan, M. Fehr, K.
Lauber, S.J. Sigrist, S. Wesselborg, K.U. Frohlich, A caspase-related protease
regulates apoptosis in yeast, Mol. Cell 9 (2002) 911–917.
[48] J.F. Sundstrom, A. Vaculova, A.P. Smertenko, E.I. Savenkov, A. Golovko, E. Minina,
B.S. Tiwari, S. Rodriguez-Nieto, A.A. Zamyatnin Jr., T. Valineva, J. Saarikettu, M.J.
Frilander, M.F. Suarez, A. Zavialov, U. Stahl, P.J. Hussey, O. Silvennoinen, E.
Sundberg, B. Zhivotovsky, P.V. Bozhkov, Tudor staphylococcal nuclease is an
evolutionarily conserved component of the programmed cell death degradome,
Nat. Cell Biol. 11 (2009) 1347–1354.
[49] J.M. Hardwick, R.J. Youle, SnapShot: BCL-2 proteins, Cell 138 (2009) 404 (404.
e1).
[50] D. Walter, S. Wissing, F. Madeo, B. Fahrenkrog, The inhibitor-of-apoptosis
protein Bir1p protects against apoptosis in S. cerevisiae and is a substrate for the
yeast homologue of Omi/HtrA2, J. Cell Sci. 119 (2006) 1843–1851.
[51] E. Abdelwahid, T. Yokokura, R.J. Krieser, S. Balasundaram, W.H. Fowle, K. White,
Mitochondrial disruption in Drosophila apoptosis, Dev. Cell. 12 (2007) 793–806.
[52] C. Claveria, E. Caminero, C. Martinez-A, S. Campuzano, M. Torres, GH3, a novel
proapoptotic domain in Drosophila Grim, promotes a mitochondrial death
pathway, EMBO J. 21 (2002) 3327–3336.
[53] M.R. Olson, C.L. Holley, E.C. Gan, D.A. Colon-Ramos, B. Kaplan, S. Kornbluth, A
GH3-like domain in reaper is required for mitochondrial localization and
induction of IAP degradation, J. Biol. Chem. 278 (2003) 44758–44768.
[54] C. Sandu, H.D. Ryoo, H. Steller, Drosophila IAP antagonists form multimeric
complexes to promote cell death, J. Cell Biol. 190 (2010) 1039–1052.
[55] W.N. Haining, C. Carboy-Newcomb, C.L. Wei, H. Steller, The proapoptotic
function of Drosophila Hid is conserved in mammalian cells, Proc. Natl. Acad.
Sci. U. S. A. 96 (1999) 4936–4941.
[56] C.D. Freel, D.A. Richardson, M.J. Thomenius, E.C. Gan, S.R. Horn, M.R. Olson, S.
Kornbluth, Mitochondrial localization of Reaper to promote inhibitors of
apoptosis protein degradation conferred by GH3 domain-lipid interactions, J.
Biol. Chem. 283 (2008) 367–379.
605E. Abdelwahid et al. / Biochimica et Biophysica Acta 1813 (2011) 597–607[57] Y. Fannjiang, W.C. Cheng, S.J. Lee, B. Qi, J. Pevsner, J.M. McCaffery, R.B. Hill, G.
Basanez, J.M. Hardwick, Mitochondrial ﬁssion proteins regulate programmed
cell death in yeast, Genes Dev. 18 (2004) 2785–2797.
[58] S. Wissing, P. Ludovico, E. Herker, S. Buttner, S.M. Engelhardt, T. Decker, A. Link,
A. Proksch, F. Rodrigues, M. Corte-Real, K.U. Frohlich, J. Manns, C. Cande, S.J.
Sigrist, G. Kroemer, F. Madeo, An AIF orthologue regulates apoptosis in yeast, J.
Cell Biol. 166 (2004) 969–974.
[59] G. Kroemer, J.C. Reed, Mitochondrial control of cell death, Nat. Med. 6 (2000)
513–519.
[60] S.W. Tait, M.J. Parsons, F. Llambi, L. Bouchier-Hayes, S. Connell, C. Munoz-Pinedo,
D.R. Green, Resistance to caspase-independent cell death requires persistence of
intact mitochondria, Dev. Cell. 18 (2010) 802–813.
[61] R.M. Kluck, E. Bossy-Wetzel, D.R. Green, D.D. Newmeyer, The release of
cytochrome c from mitochondria: a primary site for Bcl-2 regulation of
apoptosis, Science 275 (1997) 1132–1136.
[62] J. Yang, X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.I. Peng, D.P. Jones, X. Wang,
Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria
blocked, Science 275 (1997) 1129–1132.
[63] C.B. Brachmann, O.W. Jassim, B.D. Wachsmuth, R.L. Cagan, The Drosophila bcl-2
family member dBorg-1 functions in the apoptotic response to UV-irradiation,
Curr. Biol. 10 (2000) 547–550.
[64] P.A. Colussi, L.M. Quinn, D.C. Huang, M. Coombe, S.H. Read, H. Richardson, S.
Kumar, Debcl, a proapoptotic Bcl-2 homologue, is a component of the
Drosophila melanogaster cell death machinery, J. Cell Biol. 148 (2000)
703–714.
[65] T. Igaki, H. Kanuka, N. Inohara, K. Sawamoto, G. Nunez, H. Okano, M.Miura, Drob-
1, a Drosophilamember of the Bcl-2/CED-9 family that promotes cell death, Proc.
Natl. Acad. Sci. U. S. A. 97 (2000) 662–667.
[66] S. Cory, J.M. Adams, The Bcl2 family: regulators of the cellular life-or-death
switch, Nat. Rev. Cancer 2 (2002) 647–656.
[67] J. Doumanis, L. Dorstyn, S. Kumar, Molecular determinants of the subcellular
localization of the Drosophila Bcl-2 homologues DEBCL and BUFFY, Cell Death
Differ. 14 (2007) 907–915.
[68] K.A. Galindo, W.J. Lu, J.H. Park, J.M. Abrams, The Bax/Bak ortholog in Drosophila,
Debcl, exerts limited control over programmed cell death, Development 136
(2009) 275–283.
[69] H. Zhang, Q. Huang, N. Ke, S. Matsuyama, B. Hammock, A. Godzik, J.C. Reed,
Drosophila pro-apoptotic Bcl-2/Bax homologue reveals evolutionary conserva-
tion of cell death mechanisms, J. Biol. Chem. 275 (2000) 27303–27306.
[70] L. Quinn, M. Coombe, K. Mills, T. Daish, P. Colussi, S. Kumar, H. Richardson, Buffy,
a Drosophila Bcl-2 protein, has anti-apoptotic and cell cycle inhibitory functions,
EMBO J. 22 (2003) 3568–3579.
[71] J. Park, S.B. Lee, S. Lee, Y. Kim, S. Song, S. Kim, E. Bae, J. Kim, M. Shong, J.M. Kim, J.
Chung, Mitochondrial dysfunction in Drosophila PINK1 mutants is complemen-
ted by parkin, Nature 441 (2006) 1157–1161.
[72] J.N. Wu, N. Nguyen, M. Aghazarian, E.A. Sevrioukov, J.P. Monserrate, W. Tang, M.
Mabuchi, Y. Tan, K. White, C.B. Brachmann, grim promotes programmed cell
death of Drosophila microchaete glial cells, Mech. Dev. (2010).
[73] N. Senoo-Matsuda, T. Igaki, M. Miura, Bax-like protein Drob-1 protects neurons
from expanded polyglutamine-induced toxicity in Drosophila, EMBO J. 24 (14)
(2005) 2700–2713.
[74] J. Lewis, G.A. Oyler, K. Ueno, Y.R. Fannjiang, B.N. Chau, J. Vornov, S.J. Korsmeyer, S.
Zou, J.M. Hardwick, Inhibition of virus-induced neuronal apoptosis by Bax, Nat.
Med. 5 (1999) 832–835.
[75] Y. Fannjiang, C.H. Kim, R.L. Huganir, S. Zou, T. Lindsten, C.B. Thompson, T. Mito, R.
J. Traystman, T. Larsen, D.E. Grifﬁn, A.S. Mandir, T.M. Dawson, S. Dike, A.L.
Sappington, D.A. Kerr, E.A. Jonas, L.K. Kaczmarek, J.M. Hardwick, BAK alters
neuronal excitability and can switch from anti- to pro-death function during
postnatal development, Dev. Cell 4 (2003) 575–585.
[76] E.A. Sevrioukov, J. Burr, E.W. Huang, H.H. Assi, J.P. Monserrate, D.C. Purves, J.N.
Wu, E.J. Song, C.B. Brachmann, Drosophila Bcl-2 proteins participate in stress-
induced apoptosis, but are not required for normal development, Genesis 45
(2007) 184–193.
[77] P. Chen, S.I. Ho, Z. Shi, J.M. Abrams, Bifunctional killing activity encoded by
conserved reaper proteins, Cell Death Differ. 11 (2004) 704–713.
[78] X. Wang, C. Yang, J. Chai, Y. Shi, D. Xue, Mechanisms of AIF-mediated apoptotic
DNA degradation in Caenorhabditis elegans, Science 298 (2002) 1587–1592.
[79] Q. Shen, F. Qin, Z. Gao, J. Cui, H. Xiao, Z. Xu, C. Yang, Adenine nucleotide
translocator cooperates with core cell death machinery to promote apoptosis in
Caenorhabditis elegans, Mol. Cell. Biol. 29 (2009) 3881–3893.
[80] C. Wang, R.J. Youle, The role of mitochondria in apoptosis*, Annu. Rev. Genet. 43
(2009) 95–118.
[81] P. Ludovico, F. Rodrigues, A. Almeida, M.T. Silva, A. Barrientos, M. Corte-Real,
Cytochrome c release and mitochondria involvement in programmed cell death
induced by acetic acid in Saccharomyces cerevisiae, Mol. Biol. Cell 13 (2002)
2598–2606.
[82] S. Manon, B. Chaudhuri, M. Guerin, Release of cytochrome c and decrease of
cytochrome c oxidase in Bax-expressing yeast cells, and prevention of these
effects by coexpression of Bcl-xL, FEBS Lett. 415 (1997) 29–32.
[83] C. Pereira, R.D. Silva, L. Saraiva, B. Johansson, M.J. Sousa, M. Corte-Real,
Mitochondria-dependent apoptosis in yeast, Biochim. Biophys. Acta 1783
(2008) 1286–1302.
[84] C. Pereira, S. Chaves, S. Alves, B. Salin, N. Camougrand, S. Manon, M.J. Sousa, M.
Corte-Real, Mitochondrial degradation in acetic acid-induced yeast apoptosis:
the role of Pep4 and the ADP/ATP carrier, Mol. Microbiol. 76 (2010)
1398–1410.[85] P. Li, D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, E.S. Alnemri, X.
Wang, Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9
complex initiates an apoptotic protease cascade, Cell 91 (1997) 479–489.
[86] K.M. Heiskanen, M.B. Bhat, H.W. Wang, J. Ma, A.L. Nieminen, Mitochondrial
depolarization accompanies cytochrome c release during apoptosis in PC6 cells,
J. Biol. Chem. 274 (1999) 5654–5658.
[87] S. Desagher, J.C. Martinou, Mitochondria as the central control point of apoptosis,
Trends Cell Biol. 10 (2000) 369–377.
[88] N.N. Danial, S.J. Korsmeyer, Cell death: critical control points, Cell 116 (2004)
205–219.
[89] S.J. Korsmeyer, M.C. Wei, M. Saito, S. Weiler, K.J. Oh, P.H. Schlesinger, Pro-
apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that
result in the release of cytochrome c, Cell Death Differ. 7 (2000) 1166–1173.
[90] J. Varkey, P. Chen, R. Jemmerson, J.M. Abrams, Altered cytochrome c display
precedes apoptotic cell death in Drosophila, J. Cell Biol. 144 (1999) 701–710.
[91] J.C. Means, I. Muro, R.J. Clem, Lack of involvement of mitochondrial factors in
caspase activation in a Drosophila cell-free system, Cell Death Differ. 13 (2006)
1222–1234.
[92] L. Dorstyn, S. Read, D. Cakouros, J.R. Huh, B.A. Hay, S. Kumar, The role of
cytochrome c in caspase activation in Drosophila melanogaster cells, J. Cell Biol.
156 (2002) 1089–1098.
[93] K.C. Zimmermann, J.E. Ricci, N.M. Droin, D.R. Green, The role of ARK in stress-
induced apoptosis in Drosophila cells, J. Cell Biol. 156 (2002) 1077–1087.
[94] M. Challa, S. Malladi, B.J. Pellock, D. Dresnek, S. Varadarajan, Y.W. Yin, K.White, S.B.
Bratton,DrosophilaOmi, amitochondrial-localized IAP antagonist andproapoptotic
serine protease, EMBO J. 26 (2007) 3144–3156.
[95] Z. Hao, G.S. Duncan, C.C. Chang, A. Elia, M. Fang, A. Wakeham, H. Okada, T.
Calzascia, Y. Jang, A. You-Ten, W.C. Yeh, P. Ohashi, X. Wang, T.W. Mak, Speciﬁc
ablation of the apoptotic functions of cytochrome c reveals a differential
requirement for cytochrome c and Apaf-1 in apoptosis, Cell 121 (2005) 579–591.
[96] L. Dorstyn, K. Mills, Y. Lazebnik, S. Kumar, The two cytochrome c species, DC3 and
DC4, are not required for caspase activation and apoptosis in Drosophila cells, J.
Cell Biol. 167 (2004) 405–410.
[97] E. Arama, J. Agapite, H. Steller, Caspase activity and a speciﬁc cytochrome c are
required for sperm differentiation in Drosophila, Dev. Cell 4 (2003) 687–697.
[98] J.R. Huh, S.Y. Vernooy, H. Yu, N. Yan, Y. Shi, M. Guo, B.A. Hay, Multiple apoptotic
caspase cascades are required in nonapoptotic roles for Drosophila spermatid
individualization, PLoS Biol. 2 (2004) E15.
[99] E. Arama, M. Bader, M. Srivastava, A. Bergmann, H. Steller, The two Drosophila
cytochrome c proteins can function in both respiration and caspase activation,
EMBO J. 25 (2006) 232–243.
[100] C.S. Mendes, E. Arama, S. Brown, H. Scherr, M. Srivastava, A. Bergmann, H. Steller,
B. Mollereau, Cytochrome c-d regulates developmental apoptosis in the
Drosophila retina, EMBO Rep. 7 (2006) 933–939.
[101] X. Yu, L. Wang, D. Acehan, X. Wang, C.W. Akey, Three-dimensional structure of a
double apoptosome formed by the Drosophila Apaf-1 related killer, J. Mol. Biol.
355 (2006) 577–589.
[102] R. Kumarswamy, R.K. Seth, B.S. Dwarakanath, S. Chandna, Mitochondrial
regulation of insect cell apoptosis: evidence for permeability transition pore-
independent cytochrome-c release in the Lepidopteran Sf9 cells, Int. J. Biochem.
Cell Biol. 41 (2009) 1430–1440.
[103] Y. Gottfried, A. Rotem, R. Lotan, H. Steller, S. Larisch, The mitochondrial ARTS
protein promotes apoptosis through targeting XIAP, EMBO J. 23 (2004)
1627–1635.
[104] A. Oberst, C. Bender, D.R. Green, Living with death: the evolution of the
mitochondrial pathway of apoptosis in animals, Cell Death Differ. 15 (2008)
1139–1146.
[105] R. Hegde, S.M. Srinivasula, Z. Zhang, R. Wassell, R. Mukattash, L. Cilenti, G.
DuBois, Y. Lazebnik, A.S. Zervos, T. Fernandes-Alnemri, E.S. Alnemri, Identiﬁca-
tion of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts
inhibitor of apoptosis protein-caspase interaction, J. Biol. Chem. 277 (2002)
432–438.
[106] Y. Suzuki, Y. Imai, H. Nakayama, K. Takahashi, K. Takio, R. Takahashi, A serine
protease, HtrA2, is released from the mitochondria and interacts with XIAP,
inducing cell death, Mol. Cell 8 (2001) 613–621.
[107] T. Igaki, Y. Suzuki, N. Tokushige, H. Aonuma, R. Takahashi, M. Miura, Evolution of
mitochondrial cell death pathway: proapoptotic role of HtrA2/Omi in Drosophila,
Biochem. Biophys. Res. Commun. 356 (2007) 993–997.
[108] F.S. Khan, M. Fujioka, P. Datta, T. Fernandes-Alnemri, J.B. Jaynes, E.S. Alnemri, The
interaction of DIAP1 with dOmi/HtrA2 regulates cell death in Drosophila, Cell
Death Differ. 15 (2008) 1073–1083.
[109] E.S. Alnemri, HtrA2 and Parkinson's disease: think PINK? Nat. Cell Biol. 9 (2007)
1227–1229.
[110] S.A. Susin, H.K. Lorenzo, N. Zamzami, I. Marzo, B.E. Snow, G.M. Brothers, J.
Mangion, E. Jacotot, P. Costantini, M. Loefﬂer, N. Larochette, D.R. Goodlett, R.
Aebersold, D.P. Siderovski, J.M. Penninger, G. Kroemer, Molecular character-
ization of mitochondrial apoptosis-inducing factor, Nature 397 (1999)
441–446.
[111] S.A. Lipton, E. Bossy-Wetzel, Dueling activities of AIF in cell death versus
survival: DNA binding and redox activity, Cell 111 (2002) 147–150.
[112] N. Joza, K. Galindo, J.A. Pospisilik, P. Benit, M. Rangachari, E.E. Kanitz, Y.
Nakashima, G.G. Neely, P. Rustin, J.M. Abrams, G. Kroemer, J.M. Penninger, The
molecular archaeology of a mitochondrial death effector: AIF in Drosophila, Cell
Death Differ. 15 (2008) 1009–1018.
[113] J. Parrish, L. Li, K. Klotz, D. Ledwich, X.Wang, D. Xue, Mitochondrial endonuclease
G is important for apoptosis in C. elegans, Nature 412 (2001) 90–94.
606 E. Abdelwahid et al. / Biochimica et Biophysica Acta 1813 (2011) 597–607[114] A.G. Fraser, C. James, G.I. Evan, M.O. Hengartner, Caenorhabditis elegans inhibitor
of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in
cytokinesis, Curr. Biol. 9 (1999) 292–301.
[115] W. Li, L. Sun, Q. Liang, J. Wang, W. Mo, B. Zhou, Yeast AMID homologue Ndi1p
displays respiration-restricted apoptotic activity and is involved in chronological
aging, Mol. Biol. Cell 17 (2006) 1802–1811.
[116] A. Sanz, M. Soikkeli, M. Portero-Otin, A. Wilson, E. Kemppainen, G. McIlroy,
S. Ellila, K.K. Kemppainen, T. Tuomela, M. Lakanmaa, E. Kiviranta, R.
Stefanatos, E. Dufour, B. Hutz, A. Naudi, M. Jove, A. Zeb, S. Vartiainen, A.
Matsuno-Yagi, T. Yagi, P. Rustin, R. Pamplona, H.T. Jacobs, Expression of the
yeast NADH dehydrogenase Ndi1 in Drosophila confers increased lifespan
independently of dietary restriction, Proc. Natl. Acad. Sci. U. S. A. 107 (2010)
9105–9110.
[117] S. Bahadorani, J. Cho, T. Lo, H. Contreras, H.O. Lawal, D.E. Krantz, T.J. Bradley, D.W.
Walker, Neuronal expression of a single-subunit yeast NADH-ubiquinone
oxidoreductase (Ndi1) extends Drosophila lifespan, Aging Cell 9 (2010)
191–202.
[118] M. Marella, B.B. Seo, T. Yagi, A. Matsuno-Yagi, Parkinson's disease and
mitochondrial complex I: a perspective on the Ndi1 therapy, J. Bioenerg.
Biomembr. 41 (2009) 493–497.
[119] B. Fahrenkrog, U. Sauder, U. Aebi, The S. cerevisiae HtrA-like protein Nma111p is
a nuclear serine protease that mediates yeast apoptosis, J. Cell Sci. 117 (2004)
115–126.
[120] S. Buttner, T. Eisenberg, D. Carmona-Gutierrez, D. Ruli, H. Knauer, C. Ruckenstuhl,
C. Sigrist, S. Wissing, M. Kollroser, K.U. Frohlich, S. Sigrist, F. Madeo,
Endonuclease G regulates budding yeast life and death, Mol. Cell 25 (2007)
233–246.
[121] T.J. Collins, M.J. Berridge, P. Lipp, M.D. Bootman, Mitochondria are morpholog-
ically and functionally heterogeneous within cells, EMBO J. 21 (2002)
1616–1627.
[122] J.C. Martinou, R.J. Youle, Which came ﬁrst, the cytochrome c release or the
mitochondrial ﬁssion? Cell Death Differ. 13 (2006) 1291–1295.
[123] E. Smirnova, L. Griparic, D.L. Shurland, A.M. van der Bliek, Dynamin-related
protein Drp1 is required for mitochondrial division in mammalian cells, Mol.
Biol. Cell 12 (2001) 2245–2256.
[124] Y. Yoon, K.R. Pitts, M.A. McNiven, Mammalian dynamin-like protein DLP1
tubulates membranes, Mol. Biol. Cell 12 (2001) 2894–2905.
[125] D.I. James, P.A. Parone, Y. Mattenberger, J.C. Martinou, hFis1, a novel component
of the mammalian mitochondrial ﬁssion machinery, J. Biol. Chem. 278 (2003)
36373–36379.
[126] Y. Yoon, E.W. Krueger, B.J. Oswald, M.A. McNiven, The mitochondrial protein
hFis1 regulates mitochondrial ﬁssion in mammalian cells through an interaction
with the dynamin-like protein DLP1, Mol. Cell. Biol. 23 (2003) 5409–5420.
[127] D. Stojanovski, O.S. Koutsopoulos, K. Okamoto, M.T. Ryan, Levels of human Fis1 at
the mitochondrial outer membrane regulate mitochondrial morphology, J. Cell
Sci. 117 (2004) 1201–1210.
[128] M. Karbowski, S.Y. Jeong, R.J. Youle, Endophilin B1 is required for the
maintenance of mitochondrial morphology, J. Cell Biol. 166 (2004)
1027–1039.
[129] Y. Takahashi, M. Karbowski, H. Yamaguchi, A. Kazi, J. Wu, S.M. Sebti, R.J. Youle, H.
G. Wang, Loss of Bif-1 suppresses Bax/Bak conformational change and
mitochondrial apoptosis, Mol. Cell. Biol. 25 (2005) 9369–9382.
[130] D. Tondera, F. Czauderna, K. Paulick, R. Schwarzer, J. Kaufmann, A. Santel, The
mitochondrial protein MTP18 contributes to mitochondrial ﬁssion in mamma-
lian cells, J. Cell Sci. 118 (2005) 3049–3059.
[131] A. Niemann, M. Ruegg, V. La Padula, A. Schenone, U. Suter, Ganglioside-induced
differentiation associated protein 1 is a regulator of the mitochondrial network:
new implications for Charcot-Marie-Tooth disease, J. Cell Biol. 170 (2005)
1067–1078.
[132] Z. Mukamel, A. Kimchi, Death-associated protein 3 localizes to the mitochondria
and is involved in the process of mitochondrial fragmentation during cell death,
J. Biol. Chem. 279 (2004) 36732–36738.
[133] H. Chen, S.A. Detmer, A.J. Ewald, E.E. Grifﬁn, S.E. Fraser, D.C. Chan, Mitofusins
Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for
embryonic development, J. Cell Biol. 160 (2003) 189–200.
[134] S. Cipolat, O. Martins de Brito, B. Dal Zilio, L. Scorrano, OPA1 requires mitofusin 1
to promote mitochondrial fusion, Proc. Natl. Acad. Sci. U. S. A. 101 (2004)
15927–15932.
[135] H. Chen, A. Chomyn, D.C. Chan, Disruption of fusion results in mitochondrial
heterogeneity and dysfunction, J. Biol. Chem. 280 (2005) 26185–26192.
[136] D.C. Chan, Dissecting mitochondrial fusion, Dev. Cell 11 (2006) 592–594.
[137] G. Goyal, B. Fell, A. Sarin, R.J. Youle, V. Sriram, Role of mitochondrial remodeling
in programmed cell death in Drosophila melanogaster, Dev. Cell 12 (2007)
807–816.
[138] S. Frank, B. Gaume, E. Bergmann-Leitner, W.W. Leitner, E.G. Robert, F. Catez, C.L.
Smith, R.J. Youle, The role of dynamin-related protein 1, a mediator of
mitochondrial ﬁssion, in apoptosis, Dev. Cell 1 (2001) 515–525.
[139] R. Jagasia, P. Grote, B. Westermann, B. Conradt, DRP-1-mediated mitochondrial
fragmentation during EGL-1-induced cell death in C. elegans, Nature 433 (2005)
754–760.
[140] W.C. Cheng, K.M. Leach, J.M. Hardwick, Mitochondrial death pathways in yeast
and mammalian cells, Biochim. Biophys. Acta 1783 (2008) 1272–1279.
[141] D. Arnoult, A. Grodet, Y.J. Lee, J. Estaquier, C. Blackstone, Release of OPA1 during
apoptosis participates in the rapid and complete release of cytochrome c and
subsequent mitochondrial fragmentation, J. Biol. Chem. 280 (2005)
35742–35750.[142] W. Gao, Y. Pu, K.Q. Luo, D.C. Chang, Temporal relationship between cytochrome c
release and mitochondrial swelling during UV-induced apoptosis in living HeLa
cells, J. Cell Sci. 114 (2001) 2855–2862.
[143] R.J. Youle, M. Karbowski, Mitochondrial ﬁssion in apoptosis, Nat. Rev. Mol. Cell
Biol. 6 (2005) 657–663.
[144] J.C. Means, R. Hays, Mitochondrial membrane depolarization in Drosophila
apoptosis, Cell Death Differ. 14 (2007) 383–385.
[145] J.E. Chipuk, L. Bouchier-Hayes, D.R. Green, Mitochondrial outer membrane
permeabilization during apoptosis: the innocent bystander scenario, Cell Death
Differ. 13 (2006) 1396–1402.
[146] J.G. Albeck, J.M. Burke, B.B. Aldridge, M. Zhang, D.A. Lauffenburger, P.K. Sorger,
Quantitative analysis of pathways controlling extrinsic apoptosis in single cells,
Mol. Cell 30 (2008) 11–25.
[147] M.G. Sun, J. Williams, C. Munoz-Pinedo, G.A. Perkins, J.M. Brown, M.H. Ellisman,
D.R. Green, T.G. Frey, Correlated three-dimensional light and electron micros-
copy reveals transformation of mitochondria during apoptosis, Nat. Cell Biol. 9
(2007) 1057–1065.
[148] A. Tanaka, R.J. Youle, A chemical inhibitor of DRP1 uncouples mitochondrial
ﬁssion and apoptosis, Mol. Cell 29 (2008) 409–410.
[149] M. Karbowski, Y.J. Lee, B. Gaume, S.Y. Jeong, S. Frank, A. Nechushtan, A. Santel, M.
Fuller, C.L. Smith, R.J. Youle, Spatial and temporal association of Bax with
mitochondrial ﬁssion sites, Drp1, and Mfn2 during apoptosis, J. Cell Biol. 159
(2002) 931–938.
[150] T. Kanazawa, M.D. Zappaterra, A. Hasegawa, A.P. Wright, E. Newman-Smith, K.F.
Buttle, K. McDonald, C.A. Mannella, d.B. van, The C. elegansOpa1 homologue EAT-
3 is essential for resistance to free radicals, PLoS Genet. 4 (2008) e1000022.
[151] R. Ichishita, K. Tanaka, Y. Sugiura, T. Sayano, K. Mihara, T. Oka, An RNAi screen for
mitochondrial proteins required to maintain the morphology of the organelle in
Caenorhabditis elegans, J. Biochem. 143 (2008) 449–454.
[152] D.G. Breckenridge, B.H. Kang, D. Kokel, S. Mitani, L.A. Staehelin, D. Xue,
Caenorhabditis elegans drp-1 and ﬁs-2 regulate distinct cell-death execution
pathways downstream of ced-3 and independent of ced-9, Mol. Cell 31 (2008)
586–597.
[153] A.M. Labrousse, M.D. Zappaterra, D.A. Rube, d.B. van, C. elegans dynamin-related
protein DRP-1 controls severing of themitochondrial outer membrane, Mol. Cell.
4 (1999) 815–826.
[154] R. Sugioka, S. Shimizu, Y. Tsujimoto, Fzo1, a protein involved in mitochondrial
fusion, inhibits apoptosis, J. Biol. Chem. 279 (2004) 52726–52734.
[155] M. Karbowski, K.L. Norris, M.M. Cleland, S.Y. Jeong, R.J. Youle, Role of Bax and Bak
in mitochondrial morphogenesis, Nature 443 (2006) 658–662.
[156] H. Li, Y. Chen, A.F. Jones, R.H. Sanger, L.P. Collis, R. Flannery, E.C. McNay, T. Yu, R.
Schwarzenbacher, B. Bossy, E. Bossy-Wetzel, M.V. Bennett, M. Pypaert, J.A.
Hickman, P.J. Smith, J.M. Hardwick, E.A. Jonas, Bcl-xL induces Drp1-dependent
synapse formation in cultured hippocampal neurons, Proc. Natl. Acad. Sci. U.S.A.
105 (2008) 2169–2174.
[157] S.G. Rolland, Y. Lu, C.N. David, B. Conradt, The BCL-2-like protein CED-9 of C.
elegans promotes FZO-1/Mfn1, 2- and EAT-3/Opa1-dependent mitochondrial
fusion, J. Cell Biol. 186 (2009) 525–540.
[158] P. Delivani, C. Adrain, R.C. Taylor, P.J. Duriez, S.J. Martin, Role for CED-9 and Egl-1
as regulators of mitochondrial ﬁssion and fusion dynamics, Mol. Cell. 21 (2006)
761–773.
[159] F.J. Tan, M. Husain, C.M. Manlandro, M. Koppenol, A.Z. Fire, R.B. Hill, CED-9 and
mitochondrial homeostasis in C. elegans muscle, J. Cell. Sci. 121 (2006) 3373–
3382.
[160] D. Carmona-Gutierrez, T. Eisenberg, S. Buttner, C. Meisinger, G. Kroemer, F.
Madeo, Apoptosis in yeast: triggers, pathways, subroutines, Cell Death Differ. 17
(2010) 763–773.
[161] J.M. Hardwick, W.C. Cheng, Mitochondrial programmed cell death pathways in
yeast, Dev. Cell 7 (2004) 630–632.
[162] K. Okamoto, J.M. Shaw, Mitochondrial Morphology and Dynamics in Yeast and
Multicellular Eukaryotes, 2005.
[163] S. Hoppins, J. Nunnari, The molecular mechanism of mitochondrial fusion,
Biochim. Biophys. Acta 1793 (2009) 20–26.
[164] A.G. Uren, K. O'Rourke, L.A. Aravind, M.T. Pisabarro, S. Seshagiri, E.V. Koonin, V.M.
Dixit, Identiﬁcation of paracaspases and metacaspases: two ancient families of
caspase-like proteins, one of which plays a key role inMALT lymphoma, Mol. Cell
6 (2000) 961–967.
[165] J. Reiter, E. Herker, F. Madeo, M.J. Schmitt, Viral killer toxins induce caspase-
mediated apoptosis in yeast, J. Cell Biol. 168 (2005) 353–358.
[166] L. Vachova, Z. Palkova, Physiological regulation of yeast cell death in
multicellular colonies is triggered by ammonia, J. Cell Biol. 169 (2005) 711–717.
[167] M. Enoksson, G.S. Salvesen, Metacaspases are not caspases—always doubt, Cell
Death Differ. 17 (2010) 1221.
[168] W.C. Cheng, X. Teng, H.K. Park, C.M. Tucker, M.J. Dunham, J.M. Hardwick, Fis1
deﬁciency selects for compensatory mutations responsible for cell death and
growth control defects, Cell Death Differ. 15 (2008) 1838–1846.
[169] I.E. Clark, M.W. Dodson, C. Jiang, J.H. Cao, J.R. Huh, J.H. Seol, S.J. Yoo, B.A. Hay, M.
Guo, Drosophila pink1 is required for mitochondrial function and interacts
genetically with parkin, Nature 441 (2006) 1162–1166.
[170] Y. Yang, S. Gehrke, Y. Imai, Z. Huang, Y. Ouyang, J.W. Wang, L. Yang, M.F. Beal, H.
Vogel, B. Lu, Mitochondrial pathology and muscle and dopaminergic neuron
degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin,
Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10793–10798.
[171] D.P. Narendra, S.M. Jin, A. Tanaka, D.F. Suen, C.A. Gautier, J. Shen,M.R. Cookson, R.J.
Youle, PINK1 is selectively stabilized on impaired mitochondria to activate
Parkin, PLoS Biol. 8 (2010) e1000298.
607E. Abdelwahid et al. / Biochimica et Biophysica Acta 1813 (2011) 597–607[172] D. Narendra, A. Tanaka, D.F. Suen, R.J. Youle, Parkin is recruited selectively to
impaired mitochondria and promotes their autophagy, J. Cell Biol. 183 (2008)
795–803.
[173] J.C. Greene, A.J. Whitworth, I. Kuo, L.A. Andrews, M.B. Feany, L.J. Pallanck,
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila
parkin mutants, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 4078–4083.
[174] H. Deng, M.W. Dodson, H. Huang, M. Guo, The Parkinson's disease genes pink1
and parkin promote mitochondrial ﬁssion and/or inhibit fusion in Drosophila,
Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 14503–14508.
[175] E. Ziviani, R.N. Tao, A.J. Whitworth, Drosophila parkin requires PINK1 for
mitochondrial translocation and ubiquitinates mitofusin, Proc. Natl. Acad. Sci.
U. S. A. 107 (2010) 5018–5023.
[176] P. Verstreken, C.V. Ly, K.J. Venken, T.W. Koh, Y. Zhou, H.J. Bellen, Synaptic
mitochondria are critical for mobilization of reserve pool vesicles at Drosophila
neuromuscular junctions, Neuron 47 (2005) 365–378.
[177] N. Kieper, K.M. Holmstrom, D. Ciceri, F.C. Fiesel, H. Wolburg, E. Ziviani, A.J.
Whitworth, L.M. Martins, P.J. Kahle, R. Kruger, Modulation of mitochondrial
function and morphology by interaction of Omi/HtrA2 with the mitochondrial
fusion factor OPA1, Exp. Cell Res. 316 (2010) 1213–1224.
[178] C.H. Ng, S.Z. Mok, C. Koh, X. Ouyang, M.L. Fivaz, E.K. Tan, V.L. Dawson, T.M.
Dawson, F. Yu, K.L. Lim, Parkin protects against LRRK2 G2019S mutant-induced
dopaminergic neurodegeneration in Drosophila, J. Neurosci. 29 (2009)
11257–11262.
[179] K.S. Dimmer, F. Navoni, A. Casarin, E. Trevisson, S. Endele, A. Winterpacht, L.
Salviati, L. Scorrano, LETM1, deleted in Wolf-Hirschhorn syndrome is required
for normal mitochondrial morphology and cellular viability, Hum. Mol. Genet. 17
(2008) 201–214.
[180] A.G. McQuibban, N. Joza, A. Megighian, M. Scorzeto, D. Zanini, S. Reipert, C.
Richter, R.J. Schweyen, K. Nowikovsky, A Drosophila mutant of LETM1, a
candidate gene for seizures in Wolf-Hirschhorn syndrome, Hum. Mol. Genet.
19 (2010) 987–1000.
[181] J. Samann, J. Hegermann, E. von Gromoff, S. Eimer, R. Baumeister, E. Schmidt,
Caenorhabditits elegans LRK-1 and PINK-1 act antagonistically in stress response
and neurite outgrowth, J. Biol. Chem. 284 (2009) 16482–16491.
[182] C. Yao, R. El Khoury, W. Wang, T.A. Byrd, E.A. Pehek, C. Thacker, X. Zhu, M.A.
Smith, A. Wilson-Delfosse, S.G. Chen, LRRK2-mediated neurodegeneration and
dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of
Parkinson's disease, , 2010.
[183] F. Perocchi, E. Mancera, L.M. Steinmetz, Systematic screens for human disease
genes, from yeast to human and back, Mol. Biosyst. 4 (2008) 18–29.
[184] C. Schwimmer, M. Rak, L. Lefebvre-Legendre, S. Duvezin-Caubet, G. Plane, J.P. di
Rago, Yeast models of human mitochondrial diseases: from molecular mechan-
isms to drug screening, Biotechnol. J. 1 (2006) 270–281.
[185] K. Lai, M.I. Klapa, Alternative pathways of galactose assimilation: could inverse
metabolic engineering provide an alternative to galactosemic patients? Metab.
Eng. 6 (2004) 239–244.
[186] C. Polge, M. Thomas, SNF1/AMPK/SnRK1 kinases, global regulators at the heart of
energy control? Trends Plant Sci. 12 (2007) 20–28.[187] J. Garbarino, S.L. Sturley, Saturated with fat: new perspectives on lipotoxicity,
Curr. Opin. Clin. Nutr. Metab. Care 12 (2009) 110–116.
[188] K.A. Steinkraus, M. Kaeberlein, B.K. Kennedy, Replicative aging in yeast: the
means to the end, Annu. Rev. Cell Dev. Biol. 24 (2008) 29–54.
[189] A.E. Roux, P. Chartrand, G. Ferbeyre, L.A. Rokeach, Fission yeast and other yeasts
as emergent models to unravel cellular aging in eukaryotes, J. Gerontol. A Biol.
Sci. Med. Sci. 65 (2010) 1–8.
[190] M.W. Walberg, Applicability of yeast genetics to neurologic disease, Arch.
Neurol. 57 (2000) 1129–1134.
[191] J. Winderickx, C. Delay, A. De Vos, H. Klinger, K. Pellens, T. Vanhelmont, F. Van
Leuven, P. Zabrocki, Protein folding diseases and neurodegeneration: lessons
learned from yeast, Biochim. Biophys. Acta 1783 (2008) 1381–1395.
[192] J.L. Nitiss, J. Heitman, SpringerLink (Online service), Yeast as a Tool in Cancer
Research, Springer, Dordrecht, 2007.
[193] S. Lindquist, S. Krobitsch, L. Li, N. Sondheimer, Investigating protein conforma-
tion-based inheritance and disease in yeast, Philos. Trans. R. Soc. Lond. B. Biol. Sci.
356 (2001) 169–176.
[194] S. Tenreiro, T.F. Outeiro, Simple is good: yeast models of neurodegeneration,
FEMS Yeast Res. 10 (2010) 970–979.
[195] P.K. Auluck, G. Caraveo, S. Lindquist, alpha-Synuclein: membrane interactions
and toxicity in Parkinson's disease, Annu. Rev. Cell Dev. Biol. 26 (2010)
194–208.
[196] L.J. Su, P.K.Auluck, T.F.Outeiro, E. Yeger-Lotem, J.A.Kritzer,D.F. Tardiff, K.E. Strathearn,
F. Liu, S. Cao, S. Hamamichi, K.J. Hill, K.A. Caldwell, G.W. Bell, E. Fraenkel, A.A. Cooper,
G.A. Caldwell, J.M. McCaffery, J.C. Rochet, S. Lindquist, Compounds from an unbiased
chemical screen reverse both ER-to-Golgi trafﬁcking defects and mitochondrial
dysfunction in Parkinson's disease models, Dis. Model. Mech. 3 (2010) 194–208.
[197] S.A. Knight, R. Kim, D. Pain, A. Dancis, The yeast connection to Friedreich ataxia,
Am. J. Hum. Genet. 64 (1999) 365–371.
[198] D.A. Pearce, T. Ferea, S.A. Nosel, B. Das, F. Sherman, Action of BTN1, the yeast
orthologue of the gene mutated in Batten disease, Nat. Genet. 22 (1999) 55–58.
[199] S.N. Phillips, N. Muzaffar, S. Codlin, C.A. Korey, P.E. Taschner, G. de Voer, S.E.
Mole, D.A. Pearce, Characterizing pathogenic processes in Batten disease: use of
small eukaryotic model systems, Biochim. Biophys. Acta 1762 (2006) 906–919.
[200] S. Zhang, J. Ren, H. Li, Q. Zhang, J.S. Armstrong, A.L. Munn, H. Yang, Ncr1p, the
yeast ortholog of mammalian Niemann Pick C1 protein, is dispensable for
endocytic transport, Trafﬁc 5 (2004) 1017–1030.
[201] A.C. Berger, P.K. Hanson, J. Wylie Nichols, A.H. Corbett, A yeast model system for
functional analysis of the Niemann-Pick type C protein 1 homolog, Ncr1p, Trafﬁc
6 (2005) 907–917.
[202] J.K. Moore, D. Sept, J.A. Cooper, Neurodegeneration mutations in dynactin impair
dynein-dependent nuclear migration, Proc. Natl. Acad. Sci. U. S. A. 106 (2009)
5147–5152.
[203] D.A. Pearce, Hereditary spastic paraplegia: mitochondrial metalloproteases of
yeast, Hum. Genet. 104 (1999) 443–448.
[204] N. Shani, D. Valle, A Saccharomyces cerevisiae homolog of the human
adrenoleukodystrophy transporter is a heterodimer of two half ATP-binding
cassette transporters, Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 11901–11906.
